SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Amgen Inc. (AMGN)
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
1906 112 0 AMGN
Emcee:  trevor john wilkinson Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1281Tuck, thanks for keeping us updated---too busy to do real time dd on this one...zeta1961-8/3/2006
1280>>Amgen Wins TKT Appeal Thursday August 3, 2:47 pm ET THOUSAND OAKS, Caltuck-8/3/2006
1279Amgen Fights Rivals, Clock MONDAY, JULY 24, 2006 TECHNOLOGY TRADER By BIDoc Bones-7/23/2006
1278Motley Fool Amgen's Little Helpers Friday July 21, 11:31 am ET By Brian Lawmopgcw-7/22/2006
1277Amgen's Profit Decreases 99% Over Acquisition [WSJ] By DAVID P. HAMILTON JuDoc Bones-7/21/2006
1276Amgen crushes estimates (hitting the highest side of the range on revenue and EPtuck-7/20/2006
1275Takeda gets global rights to Affymax anaemia drug Tue Jun 27, 2006 6:12am ET TOnigel bates-6/27/2006
1274gs: AMGN(OP/N): Update from GS Healthcare Conference 52-Week Range US$86-60 YTDmopgcw-6/22/2006
1273CITI: AMGN: Promising Data for Aranesp in Heart Failure; Ph 3 Underway mopgcw-6/22/2006
1272citi: AMGN: Updated Timeframe for ITC Complaint re: Roche's CERA BUY (1)mopgcw-6/22/2006
1271Aranesp narrowly misses efficacy endpoints in PII heart failure and anemia trialtuck-6/20/2006
1270Same post on multiple threads, and not the most relevant one, either. Spammer, tuck-6/19/2006
1269AIDA (OTCBB:AIDA) Drug Pipeline Breaking News Aida Pharmaceuticals, Inc. (OTCBBdw981-6/19/2006
1268The PR on Priority Review came out well past the normal 60-day window from the PDewDiligence_on_SI-6/13/2006
1267I think you guessed wrong. That's OK.SirWalterRalegh-6/13/2006
1266Phase 2 Interim Data Show Denosumab Decreased Bone Turnover in Advanced Cancer Pmopgcw-6/5/2006
1265Still no word about Panitumumab Priority Review, so my guess is they didn’t get DewDiligence_on_SI-5/31/2006
1264>>Amgen Oncology Highlights Upcoming Data Presentations at the American Sotuck-5/31/2006
1263Thanks for the updates! Cheers, Tucktuck-5/25/2006
1262Citi: AMGN: Judge Young Stays in the Game; Amgen Scores A Point mopgcw-5/25/2006
1261Citi: AMGN: Roche Withdraws Personal Jurisdiction Motion Before Judge Young mopgcw-5/25/2006
1260Thanks; I'm still catching up, thought I might have missed something during tuck-5/16/2006
1259i did not. A while back they put an asterisk on their website pipeline about a mopgcw-5/16/2006
1258Did we already know AMG 714 had flopped in RA? Not a huge loss, though the newstuck-5/16/2006
1257Citi: AMGN: Opposition Response to Roche Sets Stage for Oral Hearing on 5/10 mopgcw-4/29/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News